Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
Over 20 years’ experience in supplying blinded or converted inhalation devices
The global market has a growing need for inhaled respiratory products and many comparative clinical studies against marketed products need to be conducted. When there is a marked difference between the devices, often a double dummy design is employed.
Within our pioneering innovator service, we offer blinding or conversion to placebo for many inhaler device types. When combined with our on-site analytical and QP services, our service is truly integrated and unique.
Devices and services include:
- MDI (metered dose inhaler)
- DPI (dry powder inhalers)
- DPI – capsule based
- DPI – reservoir based
- Various other formats
- Both blinding and conversion to placebo
- Innovator processes to disassemble / reassemble devices
- Production of specialised blisters in low RH for use as placebo
- Analytical services and testing to prove compliance
- Comparator procurement
Our knowledgeable specialists are available to provide guidance for your blinding or conversion, as we know that careful assessment is required for each device type.